Cocrystal Pharma Inc. (COCP) – CDI-45205 Shows Broad Activity Against COVID-19 Variants

Friday, July 30, 2021

Cocrystal Pharma Inc. (COCP)
CDI-45205 Shows Broad Activity Against COVID-19 Variants

Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.

Robert LeBoyer, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    CDI-45205 Shows Efficacy Against Delta Variant.  Cocrystal announced that its protease inhibitor against the COVID-19 virus, CDI-45205, showed potent in vitro activity against all four major variants.  These include the Delta (India or B.1.617.2), Alpha (UK or B.1.1.7), Beta (South African or B.1.351) and Gamma (Brazil or P.1). We believe these data show that the company’s technology platform for developing RNA protease inhibitors that block viral replication has broad efficacy.

    Efficacy Data Provides Proof of Concept.  CDI-45205 is based on Cocrystal’s proprietary platform for developing molecules to inhibit RNA polymerases needed for viral replication.  Inhibition of these enzymes is an early step in the viral reproductive cycle that prevents replication and stops production of new viral particles. This differs from the current COVID-19 vaccines that stimulate an immune …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Namaste Technologies Reports Second Quarter 2021 Financial Results


Namaste Technologies Reports Second Quarter 2021 Financial Results

 

  • Three Consecutive Quarters of Improved Gross Margins
  • Cannabis Revenue Increased by 18% in Q2 2021 Compared to Q2 2020
  • EBITDA Improvements in All Operating Segments

TORONTO, July 29, 2021 (GLOBE NEWSWIRE) — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) a marketplace platform for cannabis and wellness products, today reported its financial results for the second quarter ended May 31, 2021 (“Q2 2021”) with references made to financial results for the second quarter ended May 31, 2020 (“Q2 2020”). All financial figures are in Canadian dollars unless otherwise indicated.

Q2 2021 Highlights:

  • Three consecutive quarters of improved gross margins before inventory adjustments as a result of increased sales of higher margin products.
  • Gross revenue for Q2 2021 was $6.3 million, of which a strong 52% is attributable to cannabis revenues, with cannabis revenues growing 18% in Q2 2021 compared to Q2 2020.
  • Operating expenses for the six-month period decreased by 15% compared to the same period in 2020 and contributed to improved EBITDA in all operating segments. Overall EBITDA across operating segments improved 33% in Q2 2021 and 30% in Q2 YTD 2021.
  • Inventories decreased by 14% to $5.2 million in Q2 2021 ($6.0 million in the first quarter ended February 28, 2021) demonstrating continued improved inventory management practices.
  • The Company’s working capital position remains strong at $25 million as at May 31, 2021.

Re cent Corporate Highlights:

  • The Company’s wholly owned subsidiary CannMart Inc. (“CannMart”), received a Health Canada renewal of its standard licence for processing and sale of cannabis under the applicable regulations.
  • CannMart entered into a number of supply agreements including with CannTx Life Sciences Inc. (CannMart exclusive distributor on a SKU-by-SKU basis), Rilaxe Canna Inc. (CannMart exclusive distributor) and Safari Flower Co. to expand its product offering to both its provincial cannabis board buyers and its own medical customers across Canada at CannMart.com.
  • The Company’s wholly owned subsidiary CannMart Labs Inc., (“CannMartLabs”) submitted its application for a Health Canada Controlled Drugs and Substances Dealer’s Licence for future storage and distribution of the following controlled substances: psilocybin, psilocin, ketamine, LSD, DMT and MDMA.
  • As part of our sustainability initiative, the Company successfully subleased its Toronto office location until expiry of its lease on October 30, 2024, confirming its commitment to finding top talent all over the world. The decision made by the Company is an initial step towards a long-term commitment to developing an Environment, Social and Governance (ESG) plan for meaningful action to protect our planet.
  • The Company’s wholly owned Swedish subsidiary Findify AB, achieved its best ever consecutive four months of sales in the first six calendar months of 2021 with revenue per new customer up 54% and subscription sales value up 106% compared to the same period last year.
  • CannMart, signed a Master Distribution Agreement with Rapid Dose Therapeutics Corp. (“RDT”) to be the exclusive distributor of their innovative RDT branded products across Canada.
  • CannMart Labs in-house brand “Roilty” received its first purchase orders from the provinces of Manitoba and Saskatechewan for its consumer-focused cannabis concentrates.
  • SKU listings at CannMart.com increased 589% to over 800 as of the end of Q2 2021, compared to 116 in Q1 2021 as CannMart received a record amount of requests from vendors across North America to list their products onto the CannMart.com platform.

“We are very pleased with the accomplishments we have made on the operating front which include increased margins over the last three quarters as well as an improvement in EBITDA within all our operating segments,” said Meni Morim, CEO of Namaste. “While this is important, revenues were not where we wanted them to be as Covid-19 continued to have an impact on retail establishments. However, with the reduction of Covid-19 restrictions enabling greater access to retail stores, Covid-19 will have less of an impact on future revenues combined with the continuously improving margins will have a synergistic effect on our financials moving forward. In addition, we believe our various initiatives, including the impending launch of CannMart Labs, our in-house “Roilty” shatter brand hitting the shelves in the coming months, the upcoming launch of our nutraceuticals business in Q4 2021 as well as continuing to increase the number of SKUs available at CannMart.com will contribute to sales growth and improved margins over the next few quarters. We continue to be focused on controlling our operating expenses, improving gross margins and selling the right product mix to position Namaste on a clear path and trajectory towards profitability.”

For further details, the complete Financial Statements for the second quarter ended May 31, 2021 and the related Management’s Discussion & Analysis can be accessed on the Company’s SEDAR profile at www.sedar.com.

NON IFRS FINANCIAL MEASURES

Management evaluates the Company’s performance using a variety of measures, including “Net loss before income tax, depreciation and amortization” and “Adjusted EBITDA”. The non-IFRS measures discussed below should not be considered as an alternative to or to be more meaningful than revenue or net loss. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.

The Company believes these non-IFRS financial measures provide useful information to both management and investors in measuring the financial performance and financial condition of the Company.

Management uses these and other non-IFRS financial measures to exclude the impact of certain expenses and income that must be recognized under IFRS when analyzing consolidated underlying operating performance, as the excluded items are not necessarily reflective of the Company’s underlying operating performance and make comparisons of underlying financial performance between periods difficult. From time to time, the Company may exclude additional items if it believes doing so would result in a more effective analysis of underlying operating performance. The exclusion of certain items does not imply that they are non-recurring.

(i) Current and deferred income taxes, depreciation and amortization, and share-based compensation were excluded from the Adjusted EBITDA calculation as they do not represent cash expenditures.

(ii) Other income consisting of gain on disposal of subsidiary, interest income, realized gain on disposition of AFS investments, unrealized gain on derivatives and other miscellaneous non-recurring income were excluded from Adjusted EBITDA calculation.

(iii) Non-recurring costs related to restructuring and legacy issues were excluded from Adjusted EBITDA calculation.

(iv) Impairment loss relating to goodwill, customer list, domains and brand names were excluded from Adjusted EBITDA calculation.

(v) Impairment loss relating to receivable is a provision for expected credit loss to an associate and was excluded from Adjusted EBITDA calculation.

(vi) Share of associates loss, net of tax, is excluded due to lack of control.

About Namaste Technologies Inc.

Namaste Technologies is a marketplace platform for cannabis and wellness products. At CannMart.com, the Company provides Canadian medical customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators and US customers with access to hemp-derived CBD and smoking accessories. The Company also distributes licensed and in-house branded cannabis and cannabis derived products in Canada through a number of provincial government control boards and retailing bodies and facilitates licensed cannabis retailer sales online in Saskatchewan. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions.

Information on the Company and its many products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

Cannmart.com

For more information please contact:
Namaste Technologies Inc.
Meni Morim, CEO
Edward Miller, VP Investor Relations
Ph: 647-362-0390
Email: ir@namastetechnologies.com

Source: Namaste Technologies Inc

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.

The forward-looking information contained herein, including, without limitation, statements related to the Company’s expectations relating to increasing top line revenue, its intended adjustment to its product mix, the Company’s expected launch of new products and the creation of its new nutraceutical division, the Company’s continued focus on improving margins toward its goal to be profitable, are made as of the date of this press release and are based on assumptions management believed to be reasonable at the time such statements were made, including, without limitation, Namaste’s ability to maintain momentum of expanding its business, its ability to broaden its total addressable market and to evolve into a recognized wellness company, the Company’s expectation that the nutraceutical and wellness market and potentially the market for psychedelics will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, the introduction of new products and brands will generate additional revenue, the ability of the Company to turn inventory as anticipated, the impact and duration of covid-19 lockdowns on the business of the Company diminishing in the future, as well as other considerations that are believed to be appropriate in the circumstances. While the Company considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: the inability of the Company to develop its business as anticipated and to increase revenues and/or its profitable margin on such revenues, unanticipated changes to current regulations that would adversely impact the Company’s business and proposed business and other regulatory risks, risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom and risks specifically related to the Company’s operations. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Source: Namaste Technologies Inc.

 

Bunker Hill Achieves U.S. Market Upgrade to OTCQB


Bunker Hill Achieves U.S. Market Upgrade to OTCQB

 

TORONTO, July 29, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR, OTCQB: BHLL) is pleased to announce approval of its application for an upgrade to the OTCQB® Venture Market (the “OTCQB”). Bunker Hill Mining will commence trading on the OTCQB at market open on July 30, 2021, remaining under the symbol “BHLL”. Previously, the Company’s U.S. share trading was on OTC Pink, commonly referred to as the “pink sheets”.

Key benefits of the OTCQB market for investors include greater visibility and trading access within the investment community, enhanced information availability to inform trading decisions, blue sky exemptions for brokers, and higher disclosure and financial standards. The OTCQB market also aligns the Company better with its peers.

Sam Ash CEO stated, “As the next step in increasing our trading liquidity and enhancing our capital markets profile, we are very pleased to report our elevation to the OTCQB. This will increase trading access for our U.S. investors, and also serves as recognition of our enhanced governance and reporting standards.”

UPCOMING EVENTS

HCW Investment Conference

September 13-15, 2021

Join Us: REGISTER NOW

ABOUT BUNKER HILL MINING CORP.

Under new Idaho-based leadership, Bunker Hill Mining Corp. intends to sustainably restart and develop the Bunker Hill Mine as the first step in consolidating a portfolio of North American precious-metal assets with a focus on silver. Information about the Company is available on its website, www.bunkerhillmining.com , or under its profile on SEDAR and EDGAR.

For additional information contact: ir @bunkerhillmining.com

Cautionary Statements

Certain statements in this news release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as well as within the meaning of the phrase ‘forward-looking information’ in the Canadian Securities Administrators’ National Instrument 51-102 – Continuous Disclosure Obligations. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to: the potential increase in trading liquidity, the approval of the Company’s application for an upgrade to the OTCQB, and the Company’s intentions regarding its objectives, goals or future plans and statements, including the restart of the Bunker Hill Mine. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to those risks set out in the Company’s public documents filed on SEDAR and EDGAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

ACCO Brands Corporation (ACCO) – Post Call Commentary; Maintaining Outperform Rating

Friday, July 30, 2021

ACCO Brands Corporation (ACCO)
Post Call Commentary; Maintaining Outperform Rating

ACCO Brands Corporation designs, manufactures, sources, markets, and sells office products, academic supplies, and calendar products primarily in the United States, Canada, Northern Europe, Brazil, Australia, and Mexico. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers office products, such as stapling, binding and laminating equipment, and related consumable supplies, as well as shredders and whiteboards; and academic products, including notebooks, folders, decorative calendars, and stationery products. It also provides private label products, as well as business machine maintenance and repair services. The company offers its business, academic, and calendar product lines under the Artline, AT-A-GLANCE, Derwent, Esselte, Five Star, GBC, Hilroy, Leitz, Marbig, Mead, NOBO, Quartet, Rapid, Rexel, Swingline, Tilibra, Wilson Jones, and other brand names. In addition, it designs, sources, distributes, markets, and sells accessories for laptop and desktop computers, and tablets comprising security products; input devices, such as presenters, mice, and trackballs; ergonomic aids, including foot and wrist rests; docking stations; and other personal computers and tablet accessories under the Kensington, Microsaver, and ClickSafe brand names. The company sells its products to consumers and commercial end-users primarily through resellers, including traditional office supply resellers, wholesalers, mass merchandisers, and retailers, as well as directly to consumers through on-line and direct mail. ACCO Brands Corporation is headquartered in Lake Zurich, Illinois.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    PowerA Leads the Way. PowerA continues to post strong performance, even in the face of constrained console availability due to the chip shortage. While console availability constrained 2Q21 sales, at $50.7 million sales still were in management’s forecast range. We continue to expect a strong second half for PowerA.

    Operating Environment Trending Positive.  The overall operating environment continues to trend in a positive manner, although there remain some potential hiccups. The commercial business continues to improve with the return to the office of workers, worldwide economies are improving, and school instruction looks like it will return to in-classroom instruction. Commodity inflation and logistics …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Orion Group Holdings (ORN) – Surprise Quarter, But Recovery Expected

Friday, July 30, 2021

Orion Group Holdings (ORN)
Surprise Quarter, But Recovery Expected

Orion Group Holdings, based in Houston, Texas, is a specialty construction company within the Marine and Industrial Construction sectors, with operations focused in the continental United States and Caribbean. Revenue is split roughly 50/50 between a Marine Construction segment that provides marine facility, pipeline and structural construction services and a Commercial Concrete segment that provides turnkey concrete services in the light commercial and structural construction markets.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Adjusted 2Q2021 EBITDA of $7.4 million was below expectations due to wet weather. The hit from weather was mainly in Concrete and could have been as high as $10 million. Versus 2Q2020, revenue of $145.9 million was $38 million lower; gross profit of $12.3 million was $8.4 million lower and adjusted EBITDA of $7.4 million was $5.2 million lower.

    No change in 2021 EBITDA estimate following the quarterly call.  There is no change to our revised 2021 EBITDA estimate of $43.2 million, which includes asset sales of $1.6 million. The company is still facing tough comps versus last year, but Marine results should pick up over the rest of the year and Concrete continues to represent upside potential …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

HIPAA and Medical Privacy



What the HIPAA Privacy Rule Allows (A Health Law Scholar Explains)

 

The Health Insurance Portability and Accountability Act’s Privacy Rule is a federal law prohibiting health care providers, businesses and the people working with them – including administrative staff, laboratories, pharmacies, health insurers and so on – from disclosing your health information without your permission.

When people talk about HIPAA, they typically refer to the Privacy Rule provision established in 2003, which is just one part of a broader law initially passed by Congress in 1996. The Privacy Rule came into force after tennis star Arthur Ashe’s HIV status was publicly revealed and country music star Tammy Wynette’s health records were sold to tabloids. People were starting to worry about genetic privacy. And Congress recognized that the internet would make it easier for health care privacy breaches to occur.

 

Why the
HIPAA Privacy Rule Matters

The HIPAA Privacy Rule gives you the right to control your health information disclosures so you can tell your health care provider what to share. If you don’t want to share some of your health information with your family members, you can tell your health care provider to withhold that information from them.

However, HIPAA only protects health care information held by specific kinds of health care providers. For example, health care data on your Apple Watch or Fitbit is not usually covered by HIPAA. Genetic data you enter on websites like Ancestry.com is also not covered by HIPAA. Other laws or agreements like the privacy disclosures required on many apps may protect that information, but HIPAA does not.

 

Replay – Virtual Roadshow with DLH Holdings CEO Zachary Parker and CFO Kathryn JohnBull

This Virtual Road Show Presentation features a formal corporate overview from DLH CEO Zachary Parker & CFO Kathryn JohnBull. Afterwards, they are joined by Noble Capital Markets Senior Research Analyst Joe Gomes for a Q & A session featuring questions asked by the live audience throughout the event. Watch the replay, and get Noble’s research on DLHC, as well as news and advanced market data at the link below.

View All Upcoming Road Shows

 

Sometimes people try to use HIPAA as an excuse for actions it doesn’t actually cover. For instance, some people who refused to comply with coronavirus-related mask rules in stores asserted that they couldn’t be asked to explain why because of HIPAA protections. But that’s not how this privacy law works: It’s legal for someone to ask you about your vaccination status. And anyone can provide information about their own vaccination status (or any personal health information) without violating HIPAA. Are there exceptions to the HIPAA Privacy Rule?

Certain exceptions to HIPAA’s nondisclosure requirements allow covered health care providers to disclose patient information to help treat another person, protect public health and aid in certain law enforcement investigations.

During a pandemic, for instance, public health departments can provide information about how many people have tested positive for a disease, but they cannot mention specific names to the general public unless it’s necessary to alert particular people that they may have been exposed. This is because HIPAA and other privacy laws require them not to release any more information than is needed to keep people safe.

This article was republished with permission
from 
The Conversation, a news site
dedicated to sharing ideas from academic experts. It represents the research-based
findings and opinions Margaret Riley

Professor of Law, Public Health Sciences, and Public Policy, University of Virginia

 

Suggested Reading:



Scientists Now Better Understand Viral Mutations



Emerging Biotech Opportunities from an Emerging Health Problem





Psychedelics May Follow the Success of Cannabis



Elon Musk, Jack Dorsey, and Cathie Wood Drop Bombshells at Bitcoin Conference

 

Stay up to date. Follow us:

 

Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update


Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update

 

MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, August 6, 2021.

Ocugen will issue a pre-market earnings announcement on the same day. Investors are invited to participate on the call using the following details:

  • Dial-In Number: (844) 873-7330 (U.S.) or (602) 563-8473 (international)
  • Conference ID: 6663619
  • Webcast: Available in the “Investors” section of the Ocugen website and archived for approximately 45 days following the call

About?Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing?a vaccine to?save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.?We are co-developing Bharat Biotech’s COVAXIN™ vaccine candidate for COVID-19 in the U.S. and Canadian markets.?For more information, please visit www.ocugen.com.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. Such forward-looking statements within this press release include, without limitation, the intended use of net proceeds from the registered direct offering. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from our current expectations, such as market and other conditions. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (the “SEC”), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events or otherwise, after the date of this press release.

Ocugen Contact: 
Ken Inchausti
Head, Investor Relations & Communications
IR@Ocugen.com 

Please submit investor-related inquiries to: IR@ocugen.com

QuickChek – July 30, 2021



Namaste Technologies Reports Second Quarter 2021 Financial Results

Namaste Technologies announced its financial results for the second quarter ended May 31, 2021

Research, News & Market Data on Namaste Technologies

Watch recent presentation from Namaste Technologies



Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET

Ocugen announced that it will host a conference call to discuss its second quarter 2021 financial results and provide a business update

Research, News & Market Data on Ocugen

Watch recent presentation from Ocugen



Bunker Hill Achieves U.S. Market Upgrade to OTCQB

Bunker Hill Mining announced approval of its application for an upgrade to the OTCQB® Venture Market

Research, News & Market Data on Bunker Hill Mining

 

Stay up to date. Follow us:

 

Virtual Roadshow with DLH Corp. (DLHC) CEO Zachary Parker and CFO Kathryn JohnBull


DLH CEO Zachary Parker and CFO Kathryn JohnBull make a formal corporate presentation. Afterwards, they are joined by Noble Capital Markets Senior Research Analyst Joe Gomes for a Q & A session.

Research, News, and Advanced Market Data on DLHC


Information on upcoming live virtual roadshows

About DLH

DLH (NASDAQ: DLHC) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The company’s core competencies include assessment and compliance monitoring, business process outsourcing, health information technology systems integration and management, readiness and medical logistics, and pharmacy solutions.

Coeur Mining (CDE) – Under Construction

Friday, July 30, 2021

Coeur Mining (CDE)
Under Construction

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, rochester, wharf, and kensington. Its projects are located in the United States, Canada and Mexico, and North America.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Second quarter 2021 financial results. Coeur reported a second quarter adjusted loss of $840 thousand, or ($0.00) per share, compared with earnings of $2.6 million, or $0.01 per share during the prior year period. Adjusted EBITDA were $52.7 million versus $42.2 million during the second quarter of 2020. We had forecast earnings of $11.7 million, or $0.09 per share, and EBITDA of $68.5 million. Including $39.8 million of fair value adjustments such as unrealized mark-to-market gains on Coeur’s investment in Victoria Gold, unadjusted EPS and EBITDA were $0.13 and $84.6 million. Free cash flow amounted to $(20.2) million.

    Updating estimates.  We have lowered our 2021 EPS and EBITDA estimates to $0.21 and $249.0 million from $0.35 and $280.9 million. While our production estimates are unchanged, our revised estimates incorporate second quarter earnings and the company’s updated guidance with respect to certain expenses. We forecast 2022 EPS and EBITDA of $0.35 and $279.2 million, respectively …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Nuclear Powers New Paradigm Includes Microreactors



The Plug-and-Play Nuclear Battery Solution

 

“Nuclear Batteries,” or microreactors, is a proposed system that would be able to run unattended for five or ten years, provide heat for industrial processes, or electric production for communities, then be refurbished. The technological progression expected is similar to what computers experienced. Processing power that once filled rooms is now condensed into a handheld device. For nuclear generation, there’s a movement toward relatively tiny and inexpensive factory-built reactors, designed for autonomous plug-and-play. These may one day be conveniently be put into service.

Concept

In a paper published last month titled “A Strategy to Unlock the Potential of Nuclear Energy for a New and Resilient Global Energy-Industrial Paradigm,” a group of nuclear specialists presented a case for nuclear battery (NB) design and production. The idea of smaller modular nuclear reactors has been around for a while, but this proposal takes the idea even further. The authors Jacopo Buongiorno, TEPCO Professor of Nuclear Science and Engineering, MIT – Robert Freda of GE Nuclear – Steven Aumeier, Sr. Advisor for Nuclear Energy Programs at Idaho National Lab – and Kevin Chilton, Ret. Air Force Commander of U.S. Strategic Command, believe units can be made and delivered similar to modular homes. Modular units, fabricated in a factory and placed in a shipping container for delivery and quick installation.

The concept is different than previous proposals of smaller reactors in that NBs are small and complete when they leave the factory. The machines are able to generate approximately 10 megawatts of power and are transportable on one truck or container. This would provide many economic benefits. Nuclear batteries would not require a large construction site, this can eliminate cost overruns. Nuclear power plant construction has been riddled with budget-busting surprise costs for decades.  The microreactor is installed quickly, perhaps just a few weeks, and can be looked at as an energy on-demand service. Nuclear batteries would make providing nuclear energy a product, not a mega-project.

 

Nuclear Battery Advantages

The advantages are easy to understand:

  • A single 10-Megawatt NB can power about 7000 – 8000 homes, a mining project, a midsize data center, or produce enough ongoing desalinated freshwater for over 150,000 people.
  • Can bring electricity to power most anything with no need for a continuous fuel supply.
  • Completely onsite, eliminating the need for long-distance transmission or grid infrastructure.
  • Simple design, fully standardized, mass-produced, fueled at the factory with few moving parts.
  • They combine a small nuclear reactor and a turbine to supply significant amounts of heat and/or power (on the order of 15–30 MWt or 5–10 MWe) while taking up very little real estate.
  • They are compact enough to fit in standard shipping containers for transport to the site of interest, where a unit can be installed and made operational in a matter of days or weeks.
  • Embedded intelligence and established advanced monitoring paradigms enable semiautonomous and remotely monitored operation, inherent digital security, and the potential for highly efficient global fleet operational models.
  • They use low-enriched uranium fuel.
  • “Exhausted” and properly cooled NBs can be safely shipped back to a centralized facility for refueling and refurbishment.
  • There is no need for high-level radioactive waste handling or storage at the user site.[3]

The combination of low-enriched fuel, simple design, mass manufacturing, minimal site preparation, and semiautonomous operation is expected to provide an economically competitive system that can be installed fast.

 

Safety

It’s hard to mention the word nuclear without “safety” coming to mind. The NBs would be designed with three safety functions not requiring operator intervention:

  1. Rapid shutdown of the fission chain reaction in the event of an unexpected condition.
  2. Adequate cooling of the nuclear fuel during shutdown.
  3. No uncontrolled release of materials into the biosphere.

These three features are expected to significantly reduce the possibility of accidents like those experienced at Three Mile Island, Chernobyl, and Fukushima.

Physical security for microreactors would come from a combination of design features like a strong fuel and containment shell and remote monitoring.  With cybersecurity as a growing concern, vulnerability could be reduced as the design and build would be such that even a knowledgeable operator would be unable to damage the nuclear fuel or cause a radioactive release. Further, most NB designs under consideration make it physically impossible to cause a runaway reaction.

Public
Companies Involved

There are half a dozen companies developing their own Microreactor designs. These include NucNet, GE Hitachi, Radiant, and BMX Technologies. Westinghouse is working on a design that uses heat pipe technology for cooling. The company plans to run a pilot plant as a demonstration unit at one of the national laboratories in three years. Idaho National Laboratory has a number of facilities that are being modified to accommodate small reactors so they can perform testing on them.

Take-Away

We may be on the brink of a new paradigm for nuclear power.

The number of ways the future may include uranium as a power source is increasing.  Add nuclear batteries to the list as they are well suited to provide for the needs of industry and many other sectors of the economy by providing a steady, dependable source of carbon-free electricity and heat that can be located on location where power or heat is needed.

Implementation would be a few years away but demand for uranium is increasing while this and other nuclear projects such as the natrium plant in Montana are becoming a reality.

Suggested Reading:



Can You Invest in Uranium Directly?



How Does the Gates Buffett Natrium Reactor Work?





Is the Future of Nuclear Power, Small Modular Reactors?



Energy Industry Report (Q2, 2021)

 

Sources:

https://www.nae.edu/255810/A-Strategy-to-Unlock-the-Potential-of-Nuclear-Energy-for-a-New-and-Resilient-Global-EnergyIndustrial-Paradigm

https://news.mit.edu/2021/nuclear-batteries-decarbon-0625

https://inl.gov/trending-topic/microreactors/#:~:text=WHAT%20ARE%20MICROREACTORS%3F,provide%20heat%20for%20industrial%20applications.

https://www.nucnet.org/news/us-defence-department-awards-contracts-worth-usd39-million-3-2-2020

 

Stay up to date. Follow us:

 

Seanergy Maritime (SHIP) – Solid 2Q2021 Results Previews Better Second Half

Friday, July 30, 2021

Seanergy Maritime (SHIP)
Solid 2Q2021 Results Previews Better Second Half

Seanergy Maritime Holdings Corp., an international shipping company, provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. Seanergy Maritime Holdings Corp. is the only pure-play Capesize shipping company listed in the US capital markets. Seanergy provides marine dry bulk transportation services through a modern fleet of 10 Capesize vessels, with total capacity of approximately 1,748,581 dwt and an average fleet age of about 9.8 years. The Company is incorporated in the Marshall Islands with executive offices in Athens, Greece and an office in Hong Kong. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP” and class A warrants under “SHIPW”.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    2Q2021 EBITDA of $11.3 million beat our estimate of $10.1 million. Higher TCE revenue of $22.5 million and TCE rates of $20.1k/day more than offset higher opex of $8.9 million due to acquisition related expenses of $2.0 million. Operating days of 1,122 were slightly higher too.

    Moving EBITDA estimate to $73.0 million based on TCE rates of $23.4k/day, up from $71.4 million based on TCE rates of $23.1k/day to incorporate 2Q2021 results and updated forward cover.  About 59% of 3Q2021 available days of 1,448 are fixed at ~$28.5k/day due to time charters and options exercised to fix eight Capes for 3Q2021. Assuming the remaining 592 unfixed days earn ~$29.9k/day, the 3Q2021 TCE …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

ACCO Brands Corporation (ACCO) – Post Call Commentary Maintaining Outperform Rating

Friday, July 30, 2021

ACCO Brands Corporation (ACCO)
Post Call Commentary; Maintaining Outperform Rating

ACCO Brands Corporation designs, manufactures, sources, markets, and sells office products, academic supplies, and calendar products primarily in the United States, Canada, Northern Europe, Brazil, Australia, and Mexico. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers office products, such as stapling, binding and laminating equipment, and related consumable supplies, as well as shredders and whiteboards; and academic products, including notebooks, folders, decorative calendars, and stationery products. It also provides private label products, as well as business machine maintenance and repair services. The company offers its business, academic, and calendar product lines under the Artline, AT-A-GLANCE, Derwent, Esselte, Five Star, GBC, Hilroy, Leitz, Marbig, Mead, NOBO, Quartet, Rapid, Rexel, Swingline, Tilibra, Wilson Jones, and other brand names. In addition, it designs, sources, distributes, markets, and sells accessories for laptop and desktop computers, and tablets comprising security products; input devices, such as presenters, mice, and trackballs; ergonomic aids, including foot and wrist rests; docking stations; and other personal computers and tablet accessories under the Kensington, Microsaver, and ClickSafe brand names. The company sells its products to consumers and commercial end-users primarily through resellers, including traditional office supply resellers, wholesalers, mass merchandisers, and retailers, as well as directly to consumers through on-line and direct mail. ACCO Brands Corporation is headquartered in Lake Zurich, Illinois.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    PowerA Leads the Way. PowerA continues to post strong performance, even in the face of constrained console availability due to the chip shortage. While console availability constrained 2Q21 sales, at $50.7 million sales still were in management’s forecast range. We continue to expect a strong second half for PowerA.

    Operating Environment Trending Positive.  The overall operating environment continues to trend in a positive manner, although there remain some potential hiccups. The commercial business continues to improve with the return to the office of workers, worldwide economies are improving, and school instruction looks like it will return to in-classroom instruction. Commodity inflation and logistics …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.